-+ 0.00%
-+ 0.00%
-+ 0.00%

ATEA PHARMACEUTICALS - C-BEYOND PHASE 3 TOPLINE RESULTS EXPECTED MID-YEAR 2026

Reuters·06/25/2026 11:00:01

Please log in to view news